BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/27/2022 1:00:17 PM | Browse: 373 | Download: 1179
 |
Received |
|
2022-04-13 08:31 |
|
Peer-Review Started |
|
2022-04-09 16:14 |
|
First Decision by Editorial Office Director |
|
2022-06-16 01:33 |
|
Return for Revision |
|
2022-06-16 01:33 |
|
Revised |
|
2022-06-24 14:24 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-08-22 03:09 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-08-25 20:51 |
|
Articles in Press |
|
2022-08-25 20:51 |
|
Edit the Manuscript by Language Editor |
|
2022-08-16 13:36 |
|
Typeset the Manuscript |
|
2022-09-07 04:06 |
|
Publish the Manuscript Online |
|
2022-09-27 13:00 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Hematology |
| Manuscript Type |
Case Report |
| Article Title |
Treatment of refractory/relapsed extranodal NK/T cell lymphoma with decitabine plus anti-PD-1: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Lin-Jie Li and Jun-Yu Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Medical Health Science and Technology Project of Zhejiang Province Health Commission |
No. 2020376298 |
|
| Corresponding Author |
Lin-Jie Li, Doctor, Chief Doctor, Department of Hematology, Lishui Municipal Central Hospital, No. 289 KuoCang Load, Lishui 323000, Zhejiang Province, China. lilinjie0394@163.com |
| Key Words |
NK-T cell lymphoma; Refractory/relapsed; Anti-PD-1; Decitabine; Case report |
| Core Tip |
Extranodal natural killer/T cell lymphoma nasal type (ENKL) is a highly aggressive malignancy characterized by its association with Epstein-Barr virus (EBV) and extranodal involvement, which shows a poor clinical outcome. Now, we report a rare case of relapsed/refractory classic Hodgkin lymphoma with resistance to anti-PD-1 in which anti-PD-1 combined with decitabine showed positive preliminary results. Our findings support the potential benefit of anti-PD-1 combined with decitabine in this type of refractory T-cell lymphoma. |
| Publish Date |
2022-09-27 13:00 |
| Citation |
Li LJ, Zhang JY. Treatment of refractory/relapsed extranodal NK/T cell lymphoma with decitabine plus anti-PD-1: A case report. World J Clin Cases 2022; 10(28): 10193-10200 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i28/10193.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i28.10193 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
